Company intelligence / Profile preview

AVS Bio

Norwich, Connecticut, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

AVS Bio provides critical bioprocessing materials (SPF eggs, antibodies, cell products) and diagnostic/manufacturing support services for the global biologics industry, supporting both early-stage research and commercial production. The company recently expanded its capabilities in antibody discovery and recombinant protein production through the acquisition of ImmunoPrecise Antibodies Europe[1][2].

Modalities: AntibodyProteinBiologicCell product
Industry: Chemicals & Materials

Beyond the preview

Go deeper on AVS Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVS Bio.

Explore the full profile